In a recent GVHD murine study, miR-146a was under-expressed in the aGVHD group and the expression correlated with disease severity, while its target, Traf6, was overexpressed, suggesting the involvement of NFκB activity (4). Here, TRAF6 is linked to graft versus host disease.